Literature DB >> 17503133

Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.

Hayrettin Tumani1, Ingo Uttner.   

Abstract

Cognitive impairment is common also in early stages of MS, but only little is known about its relationship to standard immunotherapeutic drugs. Present data suggest that both immunosuppressive as well as immunomodulatory therapy prevent or delay the onset and severity of cognitive impairment although reversible cognitive deficits can occur.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503133     DOI: 10.1007/s00415-007-2016-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: a 1-year follow-up.

Authors:  W Gerschlager; R Beisteiner; L Deecke; G Dirnberger; W Endl; H Kollegger; G Lindinger; K Vass; W Lang
Journal:  Eur Neurol       Date:  2000       Impact factor: 1.710

Review 2.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis.

Authors:  R L Oliveri; G Sibilia; P Valentino; C Russo; N Romeo; A Quattrone
Journal:  Acta Neurol Scand       Date:  1998-06       Impact factor: 3.209

4.  Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.

Authors:  D Naber; P Sand; B Heigl
Journal:  Psychoneuroendocrinology       Date:  1996-01       Impact factor: 4.905

5.  Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults.

Authors:  C Kirschbaum; O T Wolf; M May; W Wippich; D H Hellhammer
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

6.  Cortisol effects on attentional processes in man as indicated by event-related potentials.

Authors:  J Born; W Kern; G Fehm-Wolfsdorf; H L Fehm
Journal:  Psychophysiology       Date:  1987-05       Impact factor: 4.016

7.  The effect on memory of chronic prednisone treatment in patients with systemic disease.

Authors:  P A Keenan; M W Jacobson; R M Soleymani; M D Mayes; M E Stress; D T Yaldoo
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

8.  Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.

Authors:  I Uttner; S Müller; C Zinser; M Maier; S Süssmuth; A Claus; B Ostermann; E Elitok; D Ecker; J Brettschneider; R Gold; H Tumani
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

Review 9.  [Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002].

Authors:  P Rieckmann; K V Toyka
Journal:  Nervenarzt       Date:  2002-06       Impact factor: 1.214

10.  [Cognitive impairment after accidental high-dose corticosteroid therapy].

Authors:  M Arndt; H J Kunert; H Sass; C Norra
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

View more
  1 in total

1.  White matter dementia.

Authors:  Christopher M Filley
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.